Showing 11 of 31 recruiting trials for “Hemophilia”
Enrolling by InvitationNCT05962398 ↗
Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)
👨⚕️ Arina V Zinkina-Orikhan, MD, Director of Clinical Development Department, BIOCAD📍 17 sites📅 Started May 2023View details ↗
RecruitingNCT05802836 ↗
Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.
👨⚕️ Lei Zhang, MD, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Sep 2022View details ↗
RecruitingNCT05202951 ↗
Chronic Pain and Hemophilia
👨⚕️ Aurélien LEBRETON, University Hospital, Clermont-Ferrand📍 10 sites📅 Started Feb 2022View details ↗
Trial of an Exercise Intervention for Children With Haemophilia
👨⚕️ David Stephensen, PhD, East Kent Hospitals University NHS Foundation Trust📍 1 site📅 Started May 2021View details ↗
Haemophilia and Bone Loss - PHILEOS Study
RecruitingNCT03327779 ↗
World Bleeding Disorders Registry
RecruitingNCT02912143 ↗
German Pediatric Hemophilia Research Database
RecruitingNCT02453542 ↗
Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →